本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Denali Therapeutics Inc.

16.44
+0.38002.37%
盤後16.440.00000.00%19:43 EDT
成交量:111.86萬
成交額:1,857.55萬
市值:23.88億
市盈率:-6.40
高:16.97
開:16.56
低:16.21
收:16.06
資料載入中...
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/30

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/10/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities